Eagle Asset Management Inc Alkermes Plc. Transaction History

Eagle Asset Management Inc

  • $16.7 Billion
  • Q3 2024

A detailed history of Eagle Asset Management Inc transactions in Alkermes Plc. stock. As of the latest transaction made, Eagle Asset Management Inc holds 378,718 shares of ALKS stock, worth $13.6 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
378,718
Previous 531,748 28.78%
Holding current value
$13.6 Million
Previous $12.8 Million 17.28%
% of portfolio
0.06%
Previous 0.07%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024
SELL
$23.01 - $28.55 $3.52 Million - $4.37 Million
-153,030 Reduced 28.78%
378,718 $10.6 Million
Q2 2024

Aug 12, 2024
SELL
$23.21 - $27.24 $2.03 Million - $2.38 Million
-87,463 Reduced 14.12%
531,748 $12.8 Million
Q1 2024

May 09, 2024
BUY
$26.4 - $32.56 $623,409 - $768,871
23,614 Added 3.96%
619,211 $16.8 Million
Q4 2023

Feb 12, 2024
SELL
$23.37 - $28.68 $6.36 Million - $7.81 Million
-272,276 Reduced 31.37%
595,597 $16.5 Million
Q3 2023

Nov 13, 2023
BUY
$27.17 - $31.97 $47,601 - $56,011
1,752 Added 0.2%
867,873 $24.3 Million
Q2 2023

Aug 09, 2023
BUY
$28.34 - $33.63 $1.81 Million - $2.15 Million
63,842 Added 7.96%
866,121 $27.1 Million
Q1 2023

May 08, 2023
BUY
$25.31 - $29.02 $4.09 Million - $4.68 Million
161,434 Added 25.19%
802,279 $22.6 Million
Q4 2022

Feb 14, 2023
SELL
$21.94 - $26.24 $4.71 Million - $5.63 Million
-214,695 Reduced 25.09%
640,845 $16.7 Million
Q3 2022

Nov 07, 2022
BUY
$22.0 - $31.87 $2.25 Million - $3.27 Million
102,490 Added 13.61%
855,540 $19.1 Million
Q2 2022

Aug 10, 2022
SELL
$26.4 - $30.54 $1.95 Million - $2.26 Million
-73,841 Reduced 8.93%
753,050 $22.4 Million
Q1 2022

May 12, 2022
BUY
$23.07 - $27.99 $10.7 Million - $13 Million
465,624 Added 128.89%
826,891 $21.8 Million
Q4 2021

Feb 11, 2022
SELL
$21.47 - $32.08 $1.08 Million - $1.61 Million
-50,161 Reduced 12.19%
361,267 $8.44 Million
Q3 2021

Nov 10, 2021
SELL
$23.37 - $32.13 $629,143 - $864,971
-26,921 Reduced 6.14%
411,428 $12.7 Million
Q2 2021

Aug 11, 2021
SELL
$18.78 - $25.15 $500,994 - $670,926
-26,677 Reduced 5.74%
438,349 $10.7 Million
Q1 2021

May 14, 2021
BUY
$18.21 - $23.2 $2.42 Million - $3.08 Million
132,823 Added 39.98%
465,026 $8.91 Million
Q4 2020

Feb 12, 2021
BUY
$15.39 - $22.1 $5.11 Million - $7.34 Million
332,203 New
332,203 $6.63 Million
Q1 2020

May 11, 2020
SELL
$13.06 - $21.24 $952,896 - $1.55 Million
-72,963 Closed
0 $0
Q4 2019

Feb 07, 2020
BUY
$17.29 - $21.74 $1.26 Million - $1.59 Million
72,963 New
72,963 $1.49 Million

Others Institutions Holding ALKS

# of Institutions
372
Shares Held
175M
Call Options Held
140K
Put Options Held
143K
View Full List

About Alkermes plc.

ALKS Quotes by TradingView
  • Ticker ALKS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 164,254,000
  • Market Cap $5.9B
  • Description
  • Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...
More about ALKS
Track This Portfolio

Track Eagle Asset Management Inc Portfolio

Follow Eagle Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eagle Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Eagle Asset Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email